ORB5
ORB5 is a global, gyrokinetic, Lagrangian, Particle-In-Cell (PIC), finite element, electromagnetic, GPU-enabled simulation code developed at the Swiss Plasma Center (SPC) at EPFL, with contributions from the Max-Planck IPP in Garching and Greifswald and the University of Warwick.
About ORB5
ORB5 is a global, gyrokinetic, Lagrangian, Particle-In-Cell (PIC), finite element, electromagnetic, GPU-enabled simulation code developed at the Swiss Plasma Center (SPC) at EPFL, with contributions from the Max-Planck IPP in Garching and Greifswald and the University of Warwick.
Products
A global, gyrokinetic, Lagrangian, Particle-In-Cell (PIC), finite element, electromagnetic, GPU-enabled code for plasma physics simulation, running on CPU-only and GPU-equipped...
What customers say
“KNOVA has become a strong partner in helping LEMO innovate. The connections we’ve made have enabled us to launch several new collaborative projects. We’re excited to take advantage of the size and diversity found within EPFL and in 2025, we look forward to building on the positive dynamic created over the last few years of this important relationship. Jacques Mieville, Product Innovation Manager of LEMO”
“Our goal is to stay at the cutting edge of technology. KNOVA offers a platform to exchange ideas, spark innovation, and tackle shared challenges. We value open communication with academic partners, especially EPFL, and look forward to joining events, conferences, and seminars to strengthen connections and stay ahead of emerging technologies. Asaël Droz, CTO and Board Member, Humard Automation”
“The progress we’ve made over the past three years is significant, and the EPFL environment will remain a powerful growth driver for us. Éric Bouchardy, Director of Sipchem InnoVent”
Security and compliance
As reported by ORB5. Ask for audit reports before you buy.
- Information System Security Policy (LEX 6.5.1)
- Data Protection Officer (PDO) for breach notification
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim ORB5